Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 13, 2009

View Archived Issues

NuPathe reports phase III results for Zelrix transdermal patch for migraine

FDA Advisory Committee recommends GE Healthcare's DaTSCAN

Ikaria to in-license worldwide rights to investigational fibrin-derived peptides

Javelin reports phase III results for intranasal ketamine in pain

Genmab presents preliminary topline results for Arzerra in CLL

Nycomed and Forest to collaborate on roflumilast for COPD

In vivo pharmacokinetics and metabolism data on afobazole presented at EACPT

Squalene synthase inhibitors display preclinical anti-atherosclerotic activity in recent study

Dako collaborates with Genentech on diagnostic tests for gastric cancer

PARP inhibitor PJ-34 reduces tPA-induced intracerebral hemorrhage in ischemic mice

Novel VEGF inhibitor NP-184 displays anti-angiogenic activity in preclinical study

Antithrombotic effects and improved safety shown by AVE-5026 in animal models

Wyeth receives notice from FDA for extended Prevnar 13 action date

Preliminary phase I and I/II data suggest safety and clinical activity of IMGN-901 in SCLC

Multaq approved in Canada for atrial fibrillation

Opexa enters into stem cell agreement with Novartis

Forest and AstraZeneca to codevelop and commercialize ceftaroline

Abbott discloses histamine H3 receptor ligands for the treatment of ADHD

Kissei describes COMT inhibitors for the treatment of Parkinson's disease

S1P1 receptor agonists in development at GSK

Sanofi-aventis synthesizes P2Y12 receptor antagonists useful in antiplatelet therapy

Novel vitamin D3 derivatives reported for the treatment of psoriasis

Shanghai Hengrui claims DDP IV inhibitors for the treatment of diabetes

ALK5 inhibitors in early development at Novartis for the treatment of PAH

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...